Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(884/week)
    • Manufacturing(444/week)
    • Energy(336/week)
    • Technology(890/week)
    • Environment(375/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

ViaCyte, Inc.

Feb 03, 2021
ViaCyte Announces Initiation of Phase 2 Study of Encapsulated Cell Therapy for Type 1 Diabetes Patients
Jan 27, 2021
ViaCyte Appoints Michael Yang President and CEO and Provides Company Update
Aug 13, 2020
ViaCyte Appoints Dr. Manasi Sinha Jaiman as Vice President, Clinical Development
Jul 13, 2020
ViaCyte Appoints Brittany Bradrick as Chief Financial Officer
May 28, 2020
ViaCyte to Present at the Jefferies Virtual Healthcare Conference
May 26, 2020
ViaCyte Announces $27 Million Financing to Advance Next Generation Cell Therapies for Diabetes
Jun 27, 2019
ViaCyte Appoints Sandra E. Poole to Board of Directors
Jan 29, 2019
ViaCyte Announces New Board Members
Jan 21, 2019
Center for Beta Cell Therapy in Diabetes and ViaCyte Announce Start of European Clinical Trial of Human Stem Cell-derived Implants in Type 1 Diabetes Patients
Jan 04, 2019
ViaCyte Provides Update on Patent Portfolio in Stem Cell-Derived Cell Replacement Therapies for Type 1 Diabetes and Other Indications
Nov 29, 2018
ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes
Sep 27, 2018
ViaCyte to Present at Investor, Partnering, and Scientific Conferences in October
Sep 25, 2018
Gore Strengthens Collaborative Relationship with ViaCyte by Investing Additional $10 Million
May 25, 2018
ViaCyte to Present at the American Diabetes Association's 78th Scientific Sessions
Apr 17, 2018
ViaCyte Substantially Expands Patent Portfolio in Stem Cell-Derived Cell Replacement Therapies for Type 1 Diabetes and Other Indications
Apr 12, 2018
ViaCyte to Present at Alliance for Regenerative Medicine's 6th Annual Cell & Gene Therapy Investor Day in New York City
Jan 19, 2018
ViaCyte to Present at Three Upcoming Healthcare Events
Jan 05, 2018
ViaCyte Announces First Patients Implanted in Cohort 2 with Potentially Efficacious Dose of PEC-Direct Islet Cell Replacement Therapy
Dec 15, 2017
CIRM Grants ViaCyte $1.4M to Create Immune-Evasive Pluripotent Stem Cell Lines
Dec 06, 2017
ViaCyte Selected as a Winner of CONNECT's 30th Annual Most Innovative New Product Awards
  •  
  • Page 1
  • ››

Latest News

May 29, 2025

Boyd to Exhibit at The Battery Show Europe 2025 in Stuttgart, Germany

May 29, 2025

PENETRON ADMIX Secures Brazil's Massive Cerrado Project Against Concrete Deterioration

May 29, 2025

Faraday Future Announces Results of Annual General Meeting

May 29, 2025

Gilat Receives Over $25 Million in Orders for its Multi-Orbit Satellite Solutions

May 29, 2025

QinetiQ US Wins $41 Million Task Order to Support Army Counter UAS  

May 29, 2025

EDOTCO and Sitetracker Partner to Digitally Transform Field Operations Across Asia

May 29, 2025

Hess Midstream LP Announces Pricing of Secondary Public Offering of Class A Shares

May 29, 2025

Verdant Commercial Capital Successfully Closes Fourth Asset-Backed Securitization for $400.6 Million

View all News

Agenda

23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia